Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world observational study of clofarabine injection in Chinese patients with relapsed or refractory acute lymphoblastic leukemia
CTR20250067Phase 4Active
- Sponsor
- Yifan Pharmaceutical
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clofarabine in acute lymphoblastic leukemia (ALL), sponsored by Yifan Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on CTR20250067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250067.